Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
22 p, 1.1 MB MyD88 and TLR4 Expression in Epithelial Ovarian Cancer / Block, Matthew S. (Mayo Clinic) ; Vierkant, Robert A. (Mayo Clinic) ; Rambau, Peter F. (Catholic University of Health and Allied Sciences-Bugando) ; Winham, Stacey J. (Mayo Clinic) ; Wagner, Philipp (Tübingen University Hospital) ; Traficante, Nadia (the University of Melbourne) ; Toloczko, Aleksandra (Pomeranian Medical University) ; Tiezzi, Daniel G. (University of São Paulo) ; Taran, Florin Andrei (Tübingen University Hospital) ; Sinn, Peter (Heidelberg University Hospital (Alemanya)) ; Sieh, Weiva (Icahn School of Medicine at Mount Sinai) ; Sharma, Raghwa ; Rothstein, Joseph H. (Icahn School of Medicine at Mount Sinai) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Paz-Ares, Luis (Hospital 12 de Octubre (Madrid)) ; Oszurek, Oleg (Pomeranian Medical University) ; Orsulic, Sandra (Cedars-Sinai Medical Center) ; Ness, Roberta B. (University of Texas School of Public Health) ; Nelson, Gregg (University of Calgary) ; Modugno, Francesmary (Magee-Womens Research Institute and University of Pittsburgh Cancer Institute) ; Menkiszak, Janusz (Pomeranian Medical University) ; McGuire, Valerie (Stanford University School of Medicine) ; McCauley, Bryan M. (Mayo Clinic) ; Mack, Marie (University of Cambridge) ; Lubinski, Jan (International Hereditary Cancer Center) ; Longacre, Teri A. (Stanford University) ; Li, Zheng (the Third Affiliated Hospital of Kunming Medical University (Yunnan Tumor Hospital)) ; Lester, Jenny (Cedars-Sinai Medical Center) ; Kennedy, Catherine J. (Westmead Hospital) ; Kalli, Kimberly R. (Mayo Clinic) ; Jung, Audrey Y. (German Cancer Research Center (DKFZ)) ; Johnatty, Sharon E. (QIMR Berghofer Medical Research Institute (Brisbane, Austràlia)) ; Jimenez-Linan, Mercedes (Addenbrookes Hospital (Cambridge, Regne Unit)) ; Jensen, Allan (Danish Cancer Society Research Center) ; Intermaggio, Maria P. (University of New South Wales) ; Hung, Jillian ; Herpel, Esther (University of Heidelberg) ; Hernandez, Brenda Y. (University of Hawaii) ; Hartkopf, Andreas D. (Tübingen University Hospital) ; Harnett, Paul R. ; Ghatage, Prafull (University of Calgary) ; García-Bueno, José M. (Complejo Hospitalario Universitario de Albacete) ; Gao, Bo (University of Sydney) ; Fereday, Sian ; Eilber, Ursula (German Cancer Research Center (DKFZ)) ; Edwards, Robert P. (University of Pittsburgh School of Medicine) ; de Sousa, Christiani B. (University of São Paulo) ; de Andrade, Jurandyr M. (University of São Paulo) ; Chudecka-Glaz, Anita (Pomeranian Medical University) ; Chenevix-Trench, Georgia ; Cazorla, Alicia (Hospital Universitario Fundación Jiménez Díaz) ; Brucker, Sara Y. (Tübingen University Hospital) ; Bowtell, David D. ; Green, A. ; Webb, P. ; De Fazio, Anna ; Gertig, D. ; Moore, S. ; Harrap, K. ; Sadkowsky, T. ; Pandeya, N. ; Malt, M. ; Mellon, A. ; Robertson, R. ; Vanden Bergh, T. ; Jones, M. ; Mackenzie, P. ; Maidens, J. ; Nattress, K. ; Chiew, Y.E. ; Stenlake, A. ; Sullivan, H. ; Alexander, B. ; Ashover, P. ; Brown, S. ; Corrish, T. ; Green, L. ; Jackman, L. ; Ferguson, K. ; Martin, K. ; Martyn, A. ; Ranieri, B. ; White, J. ; Jayde, V. ; Mamers, P. ; Bowes, L. ; Galletta, L. ; Giles, D. ; Hendley, J. ; Alsop, K. ; Schmidt, T. ; Shirley, H. ; Ball, C. ; Young, C. ; Viduka, S. ; Tran, H. ; Bilic, Sanela ; Glavinas, Lydia 700 1_ ; Stuart-Harris, R. ; Kirsten, F. ; Rutovitz, J. ; Clingan, P. ; Glasgow, A. ; Proietto, A. ; Braye, S. ; Otton, G. ; Shannon, J. ; Bonaventura, T. ; Stewart, J. ; Begbie, S. ; Friedlander, M. ; Bell, D. ; Baron-Hay, S. ; Ferrier, A. ; Gard, G. ; Nevell, D. ; Pavlakis, N. ; Valmadre, S. ; Young, B. ; Camaris, C. ; Crouch, R. ; Edwards, L. ; Hacker, N. ; Marsden, D. ; Robertson, G. ; Beale, P. ; Beith, J. ; Carter, J. ; Dalrymple, C. ; Houghton, R. ; Russell, P. ; Links, M. ; Grygiel, J. ; Hill, J. ; Brand, A. ; Byth, K. ; Jaworski, R. ; Wain, G. ; Ward, B. ; Papadimos, D. ; Crandon, A. ; Cummings, M. ; Horwood, K. ; Obermair, A. ; Perrin, L. ; Wyld, D. ; Nicklin, J. ; Davy, M. ; Oehler, M.K. ; Hall, C. ; Dodd, T. ; Healy, T. ; Pittman, K. ; Henderson, D. ; Miller, J. ; Pierdes, J. ; Blomfield, P. ; Challis, D. ; McIntosh, R. ; Parker, A. ; Brown, B. ; Rome, R. ; Allen, D. ; Grant, P. ; Hyde, S. ; Laurie, R. ; Robbie, M. ; Healy, D. ; Jobling, T. ; Manolitsas, T. ; McNealage, J. ; Rogers, P. ; Susil, B. ; Sumithran, E. ; Simpson, I. ; Phillips, K. ; Rischin, D. ; Fox, S. ; Johnson, D. ; Lade, S. ; Loughrey, M. ; O'Callaghan, N. ; Murray, W. ; Waring, P. ; Billson, V. ; Pyman, J. ; Neesham, D. ; Quinn, M. ; Underhill, C. ; Bell, R. ; Ng, L.F. ; Blum, R. ; Ganju, V. ; Hammond, I. ; Leung, Y. ; McCartney, A. ; Buck, M. ; Haviv, I. ; Purdie, D. ; Whiteman, D. ; Zeps, N. ; Alsop, Jennifer (University of Cambridge) ; Whittemore, Alice S. (Stanford University School of Medicine) ; Steed, Helen (Royal Alexandra Hospital) ; Staebler, Annette (Tübingen University Hospital) ; Moysich, Kirsten B. (Roswell Park Cancer Institute) ; Menon, Usha (University College London) ; Koziak, Jennifer M. (Alberta Health Services-Cancer Care) ; Kommoss, Stefan (Tübingen University Hospital) ; Kjaer, Susanne K. (University of Copenhagen) ; Kelemen, Linda E. (Medical University of South Carolina and Hollings Cancer Center) ; Karlan, Beth Y. (Cedars-Sinai Medical Center) ; Huntsman, David G. (British Columbia Cancer Agency) ; Høgdall, Estrid (University of Copenhagen) ; Gronwald, Jacek (Pomeranian Medical University) ; Goodman, Marc T. (Cedars-Sinai Medical Center) ; Gilks, Blake (Vancouver General Hospital and University of British Columbia) ; García, María José (Instituto de Salud Carlos III) ; Fasching, Peter A. (University Hospital Erlangen (Alemanya)) ; Deen, Suha (Nottingham University Hospitals NHS Trust) ; Chang-Claude, Jenny (University Medical Center Hamburg-Eppendorf) ; Candido dos Reis, Francisco J. (University of São Paulo) ; Campbell, Ian G. (University of Melbourne) ; Brenton, James D. (Cambridge Experimental Cancer Medicine Centre) ; Benitez, Javier (Instituto de Salud Carlos III) ; Pharoah, Paul D.P. (University of Cambridge) ; Köbel, Martin (University of Calgary) ; Ramus, Susan J. (Garvan Institute) ; Goode, Ellen L. (Mayo Clinic) ; Universitat Autònoma de Barcelona
To evaluate myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 (TLR4) expression in relation to clinical features of epithelial ovarian cancer, histologic subtypes, and overall survival. [...]
2018 - 10.1016/j.mayocp.2017.10.023
Mayo Clinic Proceedings, Vol. 93 Núm. 3 (january 2018) , p. 307-320  
2.
8 p, 412.5 KB Subgroup analysis in RAISE : a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression / Obermannová, R. (Masaryk Memorial Cancer Institute (Brno, República Txeca)) ; Van Cutsem, E. (University Hospitals Leuven (Bèlgica)) ; Yoshino, Takayuki (National Cancer Center Hospital East (Japan)) ; Bodoky, G. (St László Hospital (Hongria)) ; Prausová, J. (Charles University. Onocology Clinic (Czech Republic)) ; García-Carbonero, Rocío (Hospital Universitario 12 de Octubre (Madrid)) ; Ciuleanu, Tudor Eliade (Institutul Oncologic Ion Chiricuta and UMF (Romania)) ; Garcia Alfonso, P. (Hospital General Universitario Gregorio Marañón) ; Portnoy, D. (The University of Tennessee. Health Science Center (USA)) ; Cohn, A. L. (Rocky Mountain Cancer Center (USA)) ; Yamazaki, K. (Shizouka Cancer Center (Japan)) ; Clingan, P. (Southern Medical Day Care Centre (Australia)) ; Lonardi, Sara (Istituto Oncologico Veneto-IRCCS (Italy)) ; Kim, T. W. (University of Ulsan College of Medicine. Asan Medical Center (South Corea)) ; Yang, L. (Eli Lilly and Company (USA)) ; Nasroulah, F. (Eli Lilly and Company (República Argentina)) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Universitat Autònoma de Barcelona
The RAISE phase III trial demonstrated ramucirumab + FOLFIRI improved survival compared with placebo + FOLFIRI for second-line metastatic colorectal carcinoma patients previously treated with first-line bevacizumab, oxaliplatin, and a fluoropyrimidine. [...]
2016 - 10.1093/annonc/mdw402
Annals of oncology, Vol. 27, Issue 11 (November 2016) , p. 2082-2090  
3.
7 p, 199.8 KB CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab -paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer / Chiorean, E. G. (University of Washington. Department of Medicine) ; Von Hoff, D. D. (Translational Genomics Research Institute) ; Reni, Michele (Ospedale San Raffaele. Servizio di Oncologia Medica) ; Arena, F. P. (NYU Langone Arena Oncology. Department of Oncology) ; Infante, J. R. (Sarah Cannon Research Institute) ; Bathini, V. G. (University of Massachusetts Medical School. Cancer Center of Excellence) ; Wood, T. E. (University of Alabama at Birmingham. Comprehensive Cancer Center) ; Mainwaring, P. N. (Centre for Haematology & Oncology (Brisbane, Austràlia)) ; Muldoon, R. T. (Genesis Cancer Center. Department of Oncology) ; Clingan, P. (Southern Medical Day Care Centre) ; Kunzmann, V. (Universitätsklinikum Würzburg. Medizinischen Klinik und Poliklinik II) ; Ramanathan, R. K. (Translational Genomics Research Institute) ; Tabernero, Josep (Hospital Universitari Vall d'Hebron) ; Goldstein, D. (Prince of Wales Hospital (Australia)) ; McGovern, D. (Celgene Corporation) ; Lu, B. (Celgene Corporation) ; Ko, A. (Celgene Corporation) ; Universitat Autònoma de Barcelona
Any CA19-9 decline at week 8 and radiologic response by week 8 each predicted longer OS in both treatment arms. In the nab- P + Gem arm, the higher proportion of patients with week 8 CA19-9 decrease [82% (206/252); median OS 13. [...]
2016 - 10.1093/annonc/mdw006
Annals of oncology, Vol. 27, issue 4 (April 2016) , p. 654-660  

See also: similar author names
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.